A growing number of startups are turning to the Food and Drug Administration (FDA) to validate innovative interventions for autism spectrum disorder (ASD) that...
Private equity firm Fletch Equity has announced the acquisition of Autism Spectrum Interventions (ASI), a respected ABA Therapy Provider in California. This strategic move...
Autism spectrum disorder (ASD) encompasses a wide range of neurodevelopmental conditions, many of which have complex causes including genetic mutations. One significant genetic contributor...
On February 8, CentralReach, a leading software company focused on intellectual and developmental disabilities (IDD) and autism therapy, announced its acquisition of SILAS, a...
Despite some recent public missteps from high-profile ABA therapy providers, investor interest in autism services remains strong. In fact, many experts believe that Autism...
The landscape of autism therapy is facing a critical shortage of qualified providers, leaving countless families on long waitlists with limited access to essential...